These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34587819)

  • 21. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
    Khan M; Yoo SJ; Clijsters M; Backaert W; Vanstapel A; Speleman K; Lietaer C; Choi S; Hether TD; Marcelis L; Nam A; Pan L; Reeves JW; Van Bulck P; Zhou H; Bourgeois M; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Lorent N; Neyrinck A; Peetermans M; Thal DR; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
    Cell; 2021 Nov; 184(24):5932-5949.e15. PubMed ID: 34798069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.
    Bilinska K; Butowt R
    ACS Chem Neurosci; 2020 Aug; 11(15):2152-2155. PubMed ID: 32673476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
    Manzo C; Serra-Mestres J; Isetta M; Castagna A
    Med Hypotheses; 2021 Feb; 147():110479. PubMed ID: 33422806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactory disorder in patients infected with SARS-CoV-2.
    Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
    J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.
    Krishnakumar HN; Momtaz DA; Sherwani A; Mhapankar A; Gonuguntla RK; Maleki A; Abbas A; Ghali AN; Al Afif A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):505-509. PubMed ID: 36209486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Anosmia" the mysterious collateral damage of COVID-19.
    Ahmed AK; Sayad R; Mahmoud IA; El-Monem AMA; Badry SH; Ibrahim IH; Hafez MH; El-Mokhtar MA; Sayed IM
    J Neurovirol; 2022 Apr; 28(2):189-200. PubMed ID: 35249186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-viral effects of COVID-19 in the olfactory system and their implications.
    Xydakis MS; Albers MW; Holbrook EH; Lyon DM; Shih RY; Frasnelli JA; Pagenstecher A; Kupke A; Enquist LW; Perlman S
    Lancet Neurol; 2021 Sep; 20(9):753-761. PubMed ID: 34339626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and olfactory dysfunction: a looming wave of dementia?
    Kay LM
    J Neurophysiol; 2022 Aug; 128(2):436-444. PubMed ID: 35894511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tool for the psychophysical assessment of olfactory dysfunction in patients with COVID-19.
    Kim KS; Min HJ
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):102S-104S. PubMed ID: 35348400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium.
    Finlay JB; Brann DH; Abi Hachem R; Jang DW; Oliva AD; Ko T; Gupta R; Wellford SA; Moseman EA; Jang SS; Yan CH; Matsunami H; Tsukahara T; Datta SR; Goldstein BJ
    Sci Transl Med; 2022 Dec; 14(676):eadd0484. PubMed ID: 36542694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic.
    Lee JC; Nallani R; Cass L; Bhalla V; Chiu AG; Villwock JA
    Am J Rhinol Allergy; 2021 May; 35(3):323-333. PubMed ID: 32915650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients.
    Gracia DI; Ortiz M; Candela T; Iáñez E; Sánchez RM; Díaz C; Azorín JM
    Sensors (Basel); 2023 Jun; 23(13):. PubMed ID: 37447728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of olfactory dysfunction in patients of COVID-19.
    Chang CC; Yang MH; Chang SM; Hsieh YJ; Lee CH; Chen YA; Yuan CH; Chen YL; Ho SY; Tyan YC
    J Chin Med Assoc; 2021 Jul; 84(7):682-689. PubMed ID: 34074933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments.
    Najafloo R; Majidi J; Asghari A; Aleemardani M; Kamrava SK; Simorgh S; Seifalian A; Bagher Z; Seifalian AM
    ACS Chem Neurosci; 2021 Oct; 12(20):3795-3805. PubMed ID: 34609841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.
    Butowt R; von Bartheld CS
    Neuroscientist; 2021 Dec; 27(6):582-603. PubMed ID: 32914699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes.
    Mastrangelo A; Bonato M; Cinque P
    Neurosci Lett; 2021 Mar; 748():135694. PubMed ID: 33600902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report.
    Lechien JR; Michel J; Radulesco T; Chiesa-Estomba CM; Vaira LA; De Riu G; Sowerby L; Hopkins C; Saussez S
    Laryngoscope; 2020 Nov; 130(11):2526-2531. PubMed ID: 32678494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory dysfunction among patients with COVID-19.
    Alkholaiwi FM; Altamimi AF; Almalki HH; Almughaiseeb FA; Alsubaie SS; Alsayahi HS; Alhijli FW; Alobaishi RS; Agrawal A; Alqahtani ZA; Alotaibi FZ
    Saudi Med J; 2023 Nov; 44(11):1085-1103. PubMed ID: 37926445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early corticosteroid treatment enhances recovery from SARS-CoV-2 induced loss of smell in hamster.
    Merle-Nguyen L; Ando-Grard O; Bourgon C; St Albin A; Jacquelin J; Klonjkowski B; Le Poder S; Meunier N
    Brain Behav Immun; 2024 May; 118():78-89. PubMed ID: 38367845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.